Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
暂无分享,去创建一个
Nancy Hamel | W. Foulkes | N. Hamel | William D Foulkes | K. Kotar | Kimberley Kotar | William D. Foulkes
[1] H. Ostrer. A genetic profile of contemporary Jewish populations , 2001, Nature Reviews Genetics.
[2] C B Begg,et al. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[3] B. Ponder,et al. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. , 2003, American journal of human genetics.
[4] W. Foulkes,et al. A rapid fluorescent multiplexed‐PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes , 2000, Clinical genetics.
[5] M. Rubin,et al. Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men , 1999, The Prostate.
[6] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[7] W. Foulkes,et al. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. , 1999, Journal of the National Cancer Institute.
[8] D. Easton,et al. Cancer incidence in BRCA1 mutation carriers , 2003 .
[9] J. Eyfjörd,et al. BRCA2 mutation in Icelandic prostate cancer patients , 1997, Journal of Molecular Medicine.
[10] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[11] R. Stock,et al. Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer. , 1998, British Journal of Cancer.
[12] Kenneth Offit,et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% , 1996, Nature Genetics.
[13] D E Goldgar,et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. , 1997, American journal of human genetics.
[14] J. Satagopan,et al. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] D. Easton,et al. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. , 2001, American journal of human genetics.
[16] O. Manor,et al. The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. , 1999, American journal of human genetics.
[17] F. Collins,et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals , 1995, Nature Genetics.
[18] Alfred A. Boyd,et al. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 , 1996, Nature Genetics.
[19] E. Friedman,et al. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel , 2000, British Journal of Cancer.
[20] H. Olsson. Cancer risks in BRCA2 mutation carriers. , 1999, Journal of the National Cancer Institute.